Advertisement

Central Nervous System Normal Structures

  • Barbara Fullerton
  • Shannon M. MacDonald
Chapter
Part of the Practical Guides in Radiation Oncology book series (PGRO)

Abstract

Recent developments in radiation and neuro-oncology provide the ability to deliver required radiation dose to target volumes for pediatric brain tumors while avoiding sensitive normal central nervous system (CNS) structures uninvolved by tumor. Many CNS target volumes are smaller than in previous years due to better understanding of areas at risk for recurrence or involvement and patterns of spread for given diagnoses. Advances in neuroimaging and treatment planning software allow for better delineation of tumors and normal neuroanatomy. Utilization of these advances requires accurate delineation of avoidance structures. For optimal avoidance as well as accurate reporting of normal structure tolerance, it is of paramount importance to contour these structures properly. Neuroanatomy is complex and formal education in this area is not at present formally taught in radiation oncology training. This chapter is included to provide guidance for contouring of pediatric CNS structures.

References

  1. 1.
    Gordon KB, Char DH, Sagerman RH (1995) Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys 31:1123–1139CrossRefGoogle Scholar
  2. 2.
    Parsons JT, Bova FJ, Fitzgerald CR et al (1994) Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30:765–773CrossRefGoogle Scholar
  3. 3.
    Monroe AT, Bhandare N, Morris CG et al (2005) Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 61:856–864CrossRefGoogle Scholar
  4. 4.
    Constine LS, Woolf PD, Cann D et al (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87–94CrossRefGoogle Scholar
  5. 5.
    Merchant TE, Rose SR, Bosley C et al (2011) Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 29:4776–4780CrossRefGoogle Scholar
  6. 6.
    Redmond KJ, Mahone EM, Terezakis S et al (2013) Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro-Oncology 15:360–369CrossRefGoogle Scholar
  7. 7.
    Indelicato DJ, Flampouri S, Rotondo RL et al (2014) Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol 53:1298–1304CrossRefGoogle Scholar
  8. 8.
    Murphy ES, Merchant TE, Wu S et al (2012) Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 83:e655–e660CrossRefGoogle Scholar
  9. 9.
    Giantsoudi D, Sethi RV, Yeap BY et al (2016) Incidence of CNS injury for a cohort of 111 patients treated with proton therapy for medulloblastoma: LET and RBE associations for areas of injury. Int J Radiat Oncol Biol Phys 95:287–296CrossRefGoogle Scholar
  10. 10.
    MacDonald SM, Laack NN, Terezakis S (2017) Humbling advances in technology: protons, brainstem necrosis, and the self-driving car. Int J Radiat Oncol Biol Phys 97:216–219CrossRefGoogle Scholar
  11. 11.
    Hua C, Bass JK, Khan R et al (2008) Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose. Int J Radiat Oncol Biol Phys 72:892–899CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of OtolaryngologyMassachusetts Eye and Ear, Harvard Medical SchoolBostonUSA
  2. 2.Department of Radiation OncologyMassachusetts General Hospital, Francis H Burr Proton Therapy Center, Harvard Medical SchoolBostonUSA
  3. 3.Associate ProfessorHarvard Medical SchoolBostonUSA

Personalised recommendations